Literature DB >> 29063740

Submacular Hemorrhage: Visual Outcomes and Prognostic Factors.

Paradee Kunavisarut1, Tipparut Thithuan1, Direk Patikulsila1, Janejit Choovuthayakorn1, Nawat Watanachai1, Voraporn Chaikitmongkol1, Kessara Pathanapitoon1, Aniki Rothova2.   

Abstract

PURPOSE: To describe causes, visual outcomes, and prognostic factors in patients with submacular hemorrhage (SMH).
DESIGN: Retrospective case review.
METHODS: We performed a retrospective review of SMH with a size of at least 1 disc diameter. SMH causes were classified into 3 groups: 1) neovascular age-related macular degeneration (nAMD), 2) polypoidal choroidal vasculopathy (PCV), and 3) other miscellaneous causes.
RESULTS: Ninety-eight eyes of 98 patients were included. Based on clinical presentation and indocyanine green angiography (ICGA), the diagnoses of PCV (59%), nAMD (31%), and miscellaneous other causes (10%) were made. PCV patients were younger (P = 0.005) and had larger SMH size than nAMD patients (P = 0.008). Poor visual outcome [>1.0 logarithm of the minimum angle of resolution (logMAR)] at 6 months was associated with low initial visual acuity (VA; >1.0 logMAR; P = 0.002) and with the diagnosis of nAMD (P = 0.02). In addition, limited visual outcomes were noted for patients older than 65 years and those with persistent SMH for at least 2 months.
CONCLUSIONS: PCV was the most common cause of SMH in Thailand. ICGA represented a valuable tool for the diagnosis. Visual outcomes were limited for patients with nAMD and for patients who presented with poor initial VA. Copyright 2017 Asia-Pacific Academy of Ophthalmology.

Entities:  

Keywords:  indocyanine green angiography; neovascular age-related macular degeneration; polypoidal choriodal vasculopathy; submacular hemorrhage; visual outcomes

Mesh:

Substances:

Year:  2017        PMID: 29063740     DOI: 10.22608/APO.2017389

Source DB:  PubMed          Journal:  Asia Pac J Ophthalmol (Phila)        ISSN: 2162-0989


  5 in total

1.  Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration.

Authors:  Masayo Kimura; Tsutomu Yasukawa; Yu Shibata; Aki Kato; Yoshio Hirano; Akiyoshi Uemura; Munenori Yoshida; Yuichiro Ogura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-01       Impact factor: 3.117

2.  Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.

Authors:  Remzi Avcı; Ayşegül Mavi Yıldız; Esat Çınar; Sami Yılmaz; Cem Küçükerdönmez; Fatma Duriye Akalp; Emre Avcı
Journal:  Turk J Ophthalmol       Date:  2021-02-25

3.  Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration.

Authors:  Jun Hyun Lim; Yong Seop Han; Sang Joon Lee; Ki Yup Nam
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

Review 4.  Traumatic submacular hemorrhage: available treatment options and synthesis of the literature.

Authors:  Giamberto Casini; Pasquale Loiudice; Martina Menchini; Francesco Sartini; Stefano De Cillà; Michele Figus; Marco Nardi
Journal:  Int J Retina Vitreous       Date:  2019-12-11

5.  Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.

Authors:  Timothy L Jackson; Catey Bunce; Riti Desai; Jost Hillenkamp; Chan Ning Lee; Noemi Lois; Tunde Peto; Barnaby C Reeves; David H Steel; Rhiannon T Edwards; Jan C van Meurs; Hatem Wafa; Yanzhong Wang
Journal:  Trials       Date:  2022-01-31       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.